Total Payments
$9,506
2024 Payments
$3,161
Companies
32
Transactions
391
Medicare Patients
3,590
Medicare Billing
$239,047
Payment Breakdown by Category
Food & Beverage$6,959 (73.2%)
Research$2,345 (24.7%)
Education$201.54 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,959 | 370 | 73.2% |
| Unspecified | $2,345 | 17 | 24.7% |
| Education | $201.54 | 4 | 2.1% |
Payments by Type
General
$7,161
374 transactions
Research
$2,345
17 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,837 | 109 | $0 (2024) |
| Merz North America, Inc. | $810.00 | 11 | $0 (2023) |
| Janssen Biotech, Inc. | $705.26 | 31 | $0 (2024) |
| Lilly USA, LLC | $625.42 | 41 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $407.22 | 21 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $384.05 | 22 | $0 (2024) |
| PFIZER INC. | $369.50 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $295.24 | 19 | $0 (2024) |
| Galderma Laboratories, L.P. | $257.79 | 15 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $215.60 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,161 | 111 | ABBVIE INC. ($1,863) |
| 2023 | $1,456 | 76 | ABBVIE INC. ($324.92) |
| 2022 | $1,127 | 60 | ABBVIE INC. ($506.02) |
| 2021 | $1,716 | 55 | AbbVie Inc. ($1,021) |
| 2020 | $469.87 | 19 | MERZ NORTH AMERICA, INC. ($211.51) |
| 2019 | $805.11 | 23 | Merz North America, Inc. ($512.67) |
| 2018 | $430.31 | 23 | Janssen Biotech, Inc. ($129.66) |
| 2017 | $339.29 | 24 | Lilly USA, LLC ($118.33) |
All Payment Transactions
391 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.80 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: Inflammation & Immunology | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.03 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.55 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: DERMATOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study | ABBVIE INC. | $1,214 | 4 |
| A Multicenter, Double-Blind, Randomized, Placebo-Controlled Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of OnabotulinumtoxinA X for the Treatment of Moderate to Severe Glabellar Lines | ABBVIE INC. | $1,077 | 10 |
| A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants (MMP US P3 417) | ABBVIE INC. | $53.44 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 962 | 1,929 | $230,675 | $66,222 |
| 2022 | 10 | 805 | 1,790 | $187,103 | $54,994 |
| 2021 | 10 | 942 | 1,889 | $205,126 | $64,373 |
| 2020 | 10 | 881 | 1,651 | $198,769 | $53,458 |
Total Patients
3,590
Total Services
7,259
Medicare Billing
$239,047
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 233 | 343 | $54,880 | $18,581 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 188 | $44,556 | $14,130 | 31.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 171 | 261 | $37,584 | $10,043 | 26.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 84 | 102 | $21,726 | $6,589 | 30.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 50 | 65 | $15,730 | $4,748 | 30.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 93 | 163 | $32,600 | $3,977 | 12.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 120 | 728 | $8,008 | $3,275 | 40.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 16 | 21 | $6,636 | $2,523 | 38.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 23 | 30 | $3,450 | $1,129 | 32.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,555 | $931.39 | 26.2% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 13 | 13 | $1,950 | $296.53 | 15.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 210 | 318 | $50,880 | $17,348 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 141 | $33,417 | $10,223 | 30.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 158 | 245 | $35,280 | $9,346 | 26.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 64 | 73 | $15,549 | $4,888 | 31.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 112 | 813 | $8,943 | $3,627 | 40.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 36 | 43 | $10,406 | $3,055 | 29.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 69 | 106 | $21,200 | $2,554 | 12.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 14 | 21 | $6,636 | $2,528 | 38.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 11 | 19 | $2,185 | $732.45 | 33.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,607 | $692.92 | 26.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 244 | 345 | $55,200 | $19,503 | 35.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 139 | 169 | $40,053 | $13,386 | 33.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 197 | 270 | $38,880 | $10,197 | 26.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 92 | 103 | $21,939 | $6,620 | 30.2% |
About Dr. Jennifer Nash, M.D
Dr. Jennifer Nash, M.D is a Dermatology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518924299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Nash, M.D has received a total of $9,506 in payments from pharmaceutical and medical device companies, with $3,161 received in 2024. These payments were reported across 391 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,959).
As a Medicare-enrolled provider, Nash has provided services to 3,590 Medicare beneficiaries, totaling 7,259 services with total Medicare billing of $239,047. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Westerville, OH
- Active Since 04/27/2006
- Last Updated 08/13/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1518924299
Products in Payments
- BOTOX (Biological) $2,212
- SKYRIZI (Biological) $844.68
- TALTZ (Drug) $571.17
- RINVOQ (Biological) $531.80
- Sotyktu (Drug) $407.22
- TREMFYA (Drug) $367.40
- DUPIXENT (Biological) $327.51
- COSENTYX (Biological) $255.71
- EUCRISA (Drug) $205.27
- VTAMA (Drug) $197.25
- REMICADE (Biological) $181.40
- LIBTAYO (Biological) $172.80
- CIBINQO (Drug) $164.23
- OPZELURA (Drug) $163.91
- ORACEA (Drug) $115.18
- SPEVIGO (Drug) $112.45
- ILUMYA (Biological) $99.15
- Tremfya (Drug) $99.00
- HUMIRA (Biological) $78.50
- STELARA (Biological) $71.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Westerville
Dr. Joshua Grosshandler, M.d, M.D
Dermatology — Payments: $378,447
Dermatology $378,447
Jess Demaria, Md, MD
Dermatology — Payments: $195,915
Dermatology $195,915
Dr. Brittany Dulmage, M.d, M.D
Dermatology — Payments: $18,054
Dermatology $18,054
Rosina Lin, M.d, M.D
Dermatology — Payments: $17,300
Dermatology $17,300
Dr. Kevin Karikomi, D.o, D.O
Dermatology — Payments: $14,525
Dermatology $14,525
Sara Huff, Md, MD
Dermatology — Payments: $5,661
Dermatology $5,661